Tscan Therapeutics Inc (TCRX) financials · rev $10.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Tscan Therapeutics Inc (TCRX) rev $10.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $10.3M | $2.82M |
| Operating Income | -$135.8M | -$134.8M |
| Net Income | -$129.8M | -$127.5M |
| EPS (Diluted) | -$1.00 | -$1.14 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $228.8M | $371.1M |
| Current Assets | $157.2M | $292.7M |
| Cash & Equivalents | $152.4M | $178.7M |
| PP&E | $8.71M | $7.24M |
| Total Liabilities | $105.7M | $130.1M |
| Current Liabilities | $18.7M | $36.0M |
| Long-term Debt | $32.5M | $32.1M |
| Total Debt | $32.5M† | $32.1M† |
| Shareholders' Equity | $123.1M | $241.0M |
| Retained Earnings | -$504.9M | -$375.1M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$135.3M | -$110.8M |
| CapEx | $4.41M | $3.83M |
| Investing Cash Flow | $109.4M | -$52.6M |
| Financing Cash Flow | -$336.0K | $208.8M |
| Net Change in Cash | -$26.3M | $45.3M |
| Free Cash Flow | -$139.7M | -$114.6M |
FAQ
What is TCRX P/E and revenue?
Tscan Therapeutics Inc (TCRX) rev $10.3M.
What is TCRX revenue?
Tscan Therapeutics Inc last cached revenue is $10.3M (FY2025).
Is TCRX profitable?
Tscan Therapeutics Inc last cached net income is -$129.8M (FY2025).
What are TCRX total assets?
Tscan Therapeutics Inc last cached total assets are $228.8M (FY2025).
What is TCRX free cash flow?
Tscan Therapeutics Inc last cached free cash flow is -$139.7M (FY2025).
Not investment advice. Cached statements, not a live tape.